125 related articles for article (PubMed ID: 12417097)
1. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay.
Kaplan LA; Chapman JF; Bock JL; Santa Maria E; Clejan S; Huddleston DJ; Reed RG; Bernstein LH; Gillen-Goldstein J
Clin Chim Acta; 2002 Dec; 326(1-2):61-8. PubMed ID: 12417097
[TBL] [Abstract][Full Text] [Related]
2. Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ratio.
McElrath TF; Colon I; Hecht J; Tanasijevic MJ; Norwitz ER
Obstet Gynecol; 2004 Mar; 103(3):463-8. PubMed ID: 14990407
[TBL] [Abstract][Full Text] [Related]
3. Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid.
Karcher R; Sykes E; Batton D; Uddin Z; Ross G; Hockman E; Shade GH
Am J Obstet Gynecol; 2005 Nov; 193(5):1680-4. PubMed ID: 16260210
[TBL] [Abstract][Full Text] [Related]
4. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests.
Tanasijevic MJ; Winkelman JW; Wybenga DR; Richardson DK; Greene MF
Am J Clin Pathol; 1996 Jan; 105(1):17-22. PubMed ID: 8561082
[TBL] [Abstract][Full Text] [Related]
5. Gestational age-specific cutoff levels of TDx-FLM II for the prediction of neonatal respiratory distress syndrome.
Bennasar M; Figueras F; Palacio M; Bellart J; Casals E; Figueras J; Coll O; Gratacós E
Fetal Diagn Ther; 2009; 25(4):392-6. PubMed ID: 19786785
[TBL] [Abstract][Full Text] [Related]
6. Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. The Diabetes and Fetal Maturity Study Group.
Livingston EG; Herbert WN; Hage ML; Chapman JF; Stubbs TM
Obstet Gynecol; 1995 Nov; 86(5):826-9. PubMed ID: 7566857
[TBL] [Abstract][Full Text] [Related]
7. Predictive model for fetal lung maturity assessment incorporating Abbott FLM S/A II test results and obstetric estimates of gestational age.
Tanasijevic M
Clin Chim Acta; 2002 Dec; 326(1-2):1-2. PubMed ID: 12417093
[No Abstract] [Full Text] [Related]
8. A predictive model for fetal lung maturity employing gestational age and test results.
Tanasijevic MJ; Wybenga DR; Richardson D; Greene MF; Lopez R; Winkelman JW
Am J Clin Pathol; 1994 Dec; 102(6):788-93. PubMed ID: 7801892
[TBL] [Abstract][Full Text] [Related]
9. Interpretation of the TDx-FLM fluorescence polarization assay in pregnancies complicated by diabetes mellitus.
Del Valle GO; Adair CD; Ramos EE; Gaudier FL; Sanchez-Ramos L; Morales R
Am J Perinatol; 1997 May; 14(5):241-4. PubMed ID: 9259935
[TBL] [Abstract][Full Text] [Related]
10. Predicting respiratory distress syndrome using gestational age and fetal lung maturity by fluorescent polarization.
Parvin CA; Kaplan LA; Chapman JF; McManamon TG; Gronowski AM
Am J Obstet Gynecol; 2005 Jan; 192(1):199-207. PubMed ID: 15672025
[TBL] [Abstract][Full Text] [Related]
11. Amniotic fluid surfactant-albumin ratio as a screening test for fetal lung maturity. Two years of clinical experience.
Bayer-Zwirello LA; Jertson J; Rosenbaum J; Moccio R; O'Grady JP; Kanaan CM; Gimovsky ML
J Perinatol; 1993; 13(5):354-60. PubMed ID: 8263619
[TBL] [Abstract][Full Text] [Related]
12. Lamellar body counts in amniotic fluid for prediction of fetal lung maturity.
Beinlich A; Fischäss C; Kaufmann M; Schlösser R; Dericks-Tan JS
Arch Gynecol Obstet; 1999; 262(3-4):173-80. PubMed ID: 10326636
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the diagnostic accuracy of the TDx-FLM II to predict fetal lung maturity.
Fantz CR; Powell C; Karon B; Parvin CA; Hankins K; Dayal M; Sadovsky Y; Johari V; Apple FS; Gronowski AM
Clin Chem; 2002 May; 48(5):761-5. PubMed ID: 11978603
[TBL] [Abstract][Full Text] [Related]
14. A direct comparison between lamellar body counts and fluorescent polarization methods for predicting respiratory distress syndrome.
Haymond S; Luzzi VI; Parvin CA; Gronowski AM
Am J Clin Pathol; 2006 Dec; 126(6):894-9. PubMed ID: 17074687
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the NBD-PC fluorescence polarization assay for prediction of fetal lung maturity.
Chen C; Roby PV; Weiss NS; Wilson JA; Benedetti TJ; Tait JF
Obstet Gynecol; 1992 Oct; 80(4):688-92. PubMed ID: 1407896
[TBL] [Abstract][Full Text] [Related]
16. [Prenatal determination of lung maturity from amniotic fluid--indications and new methods].
Ragosch V; Hundertmark S; Stolowsky C; Lorenz U; Arabin B; Weitzel H
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):679-84. PubMed ID: 7851709
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of fetal lung maturity using newly developed immunological measurement of fetal pulmonary surfactant apoprotein-A in amniotic fluid].
Satoh K; Sakata H; Nishijima S; Fujimoto S; Koga Y; Nakano H; Maeda H; Matsumoto N; Nakabayashi M; Takagi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1269-76. PubMed ID: 1431440
[TBL] [Abstract][Full Text] [Related]
18. Preanalytical factors that influence the Abbott TDx Fetal Lung Maturity II assay.
Grenache DG; Parvin CA; Gronowski AM
Clin Chem; 2003 Jun; 49(6 Pt 1):935-9. PubMed ID: 12765990
[TBL] [Abstract][Full Text] [Related]
19. Clinical implementation of a rapid, automated assay for assessing fetal lung maturity.
Apple FS; Bilodeau L; Preese LM; Benson P
J Reprod Med; 1994 Nov; 39(11):883-7. PubMed ID: 7853280
[TBL] [Abstract][Full Text] [Related]
20. Prediction of fetal lung immaturity using gestational age, patient characteristics and fetal lung maturity tests: a probabilistic approach.
Wijnberger LD; de Kleine M; Voorbij HA; Arabin B; Bruinse HW; Visser GH; Bossuyt PM; Mol BW
Arch Gynecol Obstet; 2010 Jan; 281(1):15-21. PubMed ID: 19381669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
